Micro method for determination of nonesterified fatty acid in whole blood obtained by fingertip puncture

Analytical Biochemistry

Volumn 355, Issue 1, 2006, Pages 29-38

  Hansen, Jesper S ^a   Villadsen, Jens K ^a   Gaster, Michael ^b   Færgeman, Nils J ^a   Knudsen, Jens ^a  

^a UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^b ODENSE UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Acyl CoA binding protein; Diagnostics; Nonesterified fatty acids; Type 2 diabetes

Indexed keywords

AMINO ACIDS; DIAGNOSIS; ESTERS; FLUORESCENCE; MAMMALS; NUTRITION; PALMITIC ACID; PLASMA DIAGNOSTICS; PROTEINS;

ACYL-COA BINDING PROTEINS; ACYL-COA SYNTHETASE; CYSTEINE RESIDUES; DIAGNOSTIC TOOLS; EXTERNAL STANDARDS; FLUORESCENCE EMISSION; NONESTERIFIED FATTY ACIDS; TYPE-2 DIABETES;

BLOOD;

ACYL COENZYME A; ADENOSINE TRIPHOSPHATE; ALCOHOL; BINDING PROTEIN; COENZYME A; FATTY ACID; LONG CHAIN FATTY ACID COENZYME A LIGASE; PALMITOYL COENZYME A;

ARTICLE; BLOOD ANALYSIS; CONTROLLED STUDY; COVALENT BOND; DIAGNOSTIC ACCURACY; FATTY ACID ANALYSIS; FATTY ACID BLOOD LEVEL; FLUORESCENCE ANALYSIS; HUMAN; INCUBATION TIME; OPTICAL BIOSENSOR; PRIORITY JOURNAL; PUNCTURE; REPRODUCIBILITY;

BOS TAURUS;

EID: 33745885671     PISSN: 00032697     EISSN: 10960309     Source Type: Journal    
DOI: 10.1016/j.ab.2006.04.054     Document Type: Article

References (42)

1. Amery C.M., and Nattrass M. Fatty acids and insulin secretion. Diabetes Obes. Metab. 2 (2000) 213-221
2. Leaf A. Plasma nonesterified fatty acid concentration as a risk factor for sudden cardiac death: The Paris Prospective Study. Circulation 104 (2001) 744-745
3. Haber E.P., Ximenes H.M., Procopio J., Carvalho C.R., Curi R., and Carpinelli A.R. Pleiotropic effects of fatty acids on pancreatic beta-cells. J. Cell Physiol. 194 (2003) 1-12
4. Duplus E., Glorian M., and Forest C. Fatty acid regulation of gene transcription. J. Biol. Chem. 275 (2000) 30749-30752
5. Clarke S.D., Thuillier P., Baillie R.A., and Sha X. Peroxisome proliferator-activated receptors: a family of lipid-activated transcription factors. Am. J. Clin. Nutr. 70 (1999) 566-571
6. Krey G., Braissant O., L'Horset F., Kalkhoven E., Perroud M., Parker M.G., and Wahli W. Fatty acids, eicosanoids, and hypolipidemic agents identified as ligands of peroxisome proliferator-activated receptors by coactivator-dependent receptor ligand assay. Mol. Endocrinol. 11 (1997) 779-791
7. Schoonjans K., Staels B., and Auwerx J. Role of the peroxisome proliferator-activated receptor (PPAR) in mediating the effects of fibrates and fatty acids on gene expression. J. Lipid Res. 37 (1996) 907-925
8. McGarry J.D. Banting lecture 2001: dysregulation of fatty acid metabolism in the etiology of type 2 diabetes. Diabetes 51 (2002) 7-18
9. Hajduch E., Balendran A., Batty I.H., Litherland G.J., Blair A.S., Downes C.P., and Hundal H.S. Ceramide impairs the insulin-dependent membrane recruitment of protein kinase B leading to a loss in downstream signalling in L6 skeletal muscle cells. Diabetologia 44 (2001) 173-183
10. Hegarty B.D., Cooney G.J., Kraegen E.W., and Furler S.M. Increased efficiency of fatty acid uptake contributes to lipid accumulation in skeletal muscle of high fat-fed insulin-resistant rats. Diabetes 51 (2002) 1477-1484
11. Chavez J.A., and Summers S.A. Characterizing the effects of saturated fatty acids on insulin signaling and ceramide and diacylglycerol accumulation in 3T3-L1 adipocytes and C2C12 myotubes. Arch. Biochem. Biophys. 419 (2003) 101-109
12. Lillioja S., Mott D.M., Spraul M., Ferraro R., Foley J.E., Ravussin E., Knowler W.C., Bennett P.H., and Bogardus C. Insulin resistance and insulin secretory dysfunction as precursors of non-insulin-dependent diabetes mellitus: prospective studies of Pima Indians. N. Engl. J. Med. 329 (1993) 1988-1992
13. Stefan N., Stumvoll M., Bogardus C., and Tataranni P.A. Elevated plasma nonesterified fatty acids are associated with deterioration of acute insulin response in IGT but not NGT. Am. J. Physiol. Endocrinol. Metab. 284 (2003) E1156-E1161
14. Charles M.A., Eschwege E., Thibult N., Claude J.R., Warnet J.M., Rosselin G.E., Girard J., and Balkau B. The role of non-esterified fatty acids in the deterioration of glucose tolerance in Caucasian subjects: results of the Paris Prospective Study. Diabetologia 40 (1997) 1101-1106
15. Laaksonen D.E., Lakka T.A., Lakka H.M., Nyyssonen K., Rissanen T., Niskanen L.K., and Salonen J.T. Serum fatty acid composition predicts development of impaired fasting glycaemia and diabetes in middle-aged men. Diabet. Med. 19 (2002) 456-464
16. Jouven X., Charles M.A., Desnos M., and Ducimetiere P. Circulating nonesterified fatty acid level as a predictive risk factor for sudden death in the population. Circulation 104 (2001) 756-761
17. Carlsson M., Wessman Y., Almgren P., and Groop L. High levels of nonesterified fatty acids are associated with increased familial risk of cardiovascular disease. Arterioscler. Thromb. Vasc. Biol. 20 (2000) 1588-1594
18. Taniguchi A., Sakai M., Teramura S., Fukushima M., Hama K., Marumoto K., Nezumi N., Yoshida T., Nagasaka S., Hayashi R., Tokuyama K., and Nakai Y. Serum nonesterified fatty acids are related with carotid atherosclerotic plaque in nonobese nonhypertensive Japanese type 2 diabetic patients. Diabetes Care 24 (2001) 1505-1507
19. Charles M.A., Fontbonne A., Thibult N., Claude J.R., Warnet J.M., Rosselin G., Ducimetiere P., and Eschwege E. High plasma nonesterified fatty acids are predictive of cancer mortality but not of coronary heart disease mortality: results from the Paris Prospective Study. Am. J. Epidemiol. 153 (2001) 292-298
20. Frayn K.N., Williams C.M., and Arner P. Are increased plasma non-esterified fatty acid concentrations a risk marker for coronary heart disease and other chronic diseases?. Clin. Sci. (Lond.) 90 (1996) 243-253
21. Shimizu S., Inoue K., Tani Y., and Yamada H. Enzymatic microdetermination of serum free fatty acids. Anal. Biochem. 98 (1979) 341-345
22. Shimizu S., Tani Y., Yamada H., Tabata M., and Murachi T. Enzymatic determination of serum-free fatty acids: a colorimetric method. Anal. Biochem. 107 (1980) 193-198
23. Okabe H., Uji Y., Nagashima K., and Noma A. Enzymic determination of free fatty acids in serum. Clin. Chem. 26 (1980) 1540-1543
24. Hosaka K., Kikuchi T., Mitsuhida N., and Kawaguchi A. A new colorimetric method for the determination of free fatty acids with acyl-CoA synthetase and acyl-CoA oxidase. J. Biochem. (Tokyo) 89 (1981) 1799-1803
25. Matsubara C., Nishikawa Y., Yoshida Y., and Takamura K. A spectrophotometric method for the determination of free fatty acid in serum using acyl-coenzyme A synthetase and acyl-coenzyme A oxidase. Anal. Biochem. 130 (1983) 128-133
26. Kather H., and Wieland E. Bioluminescent determination of free fatty acids. Anal. Biochem. 140 (1984) 349-353
27. Carr R.E., Humphreys S.M., and Frayn K.N. Catecholamine interference with enzymatic determination of nonesterified fatty acids in two commercially available test kits. Clin. Chem. 41 (1995) 455-457
28. Christmass M.A., Mitoulas L.R., Hartmann P.E., and Arthur P.G. A semiautomated enzymatic method for determination of nonesterified fatty acid concentration in milk and plasma. Lipids 33 (1998) 1043-1049
29. Demacker P.N., Hijmans A.G., and Jansen A.P. Enzymic and chemical-extraction determinations of free fatty acids in serum compared. Clin. Chem. 28 (1982) 1765-1768
30. Miles J., Glasscock R., Aikens J., Gerich J., and Haymond M. A microfluorometric method for the determination of free fatty acids in plasma. J. Lipid Res. 24 (1983) 96-99
31. Wadum M.C., Villadsen J.K., Feddersen S., Moller R.S., Neergaard T.B., Kragelund B.B., Hojrup P., Faergeman N.J., and Knudsen J. Fluorescently labelled bovine acyl-CoA-binding protein acting as an acyl-CoA sensor: interaction with CoA and acyl-CoA esters and its use in measuring free acyl-CoA esters and non-esterified fatty acids. Biochem. J. 365 (2002) 165-172
32. Fisher C.L., and Pei G.K. Modification of a PCR-based site-directed mutagenesis method. BioTechniques 23 (1997) 570-574
33. Jiang D.W., and Englund P.T. Four Trypanosoma brucei fatty acyl-CoA synthetases: fatty acid specificity of the recombinant proteins. Biochem. J. 358 (2001) 757-761
34. Wanders R.J., van Roermund C.W., van Wijland M.J., Schutgens R.B., Schram A.W., van den Bosch H., and Tager J.M. Studies on the peroxisomal oxidation of palmitate and lignocerate in rat liver. Biochim. Biophys. Acta 919 (1987) 21-25
35. Sprott J.C. Numerical Recipes, Routines, and Examples in BASIC (1991), Cambridge University Press, New York
36. Marquardt D.W. An algorithm for least-squares estimation of nonlinear parameters. J. Soc. Ind. Appl. Math. 11 (1963) 431-441
37. Kragelund B.B., Andersen K.V., Madsen J.C., Knudsen J., and Poulsen F.M. Three-dimensional structure of the complex between acyl-coenzyme A binding protein and palmitoyl-coenzyme A. J. Mol. Biol. 230 (1993) 1260-1277
38. Faergeman N.J., Sigurskjold B.W., Kragelund B.B., Andersen K.V., and Knudsen J. Thermodynamics of ligand binding to acyl-coenzyme A binding protein studied by titration calorimetry. Biochemistry 35 (1996) 14118-14126
39. 2+ release channel of skeletal muscle sarcoplasmic reticulum. Biochem. J. 325 (1997) 423-428
40. Rolf B., Oudenampsen-Kruger E., Borchers T., Faergeman N.J., Knudsen J., Lezius A., and Spener F. Analysis of the ligand binding properties of recombinant bovine liver-type fatty acid binding protein. Biochim. Biophys. Acta 1259 (1995) 245-253
41. Demant E.J. Bovine serum albumin-(7-hydroxycoumarin-4-acetic acid) complex: applications to the fluorometric measurement of fatty acid concentrations. Anal. Biochem. 267 (1999) 366-372
42. Lin L.I.-K. A concordance correlation coefficient to evaluate reproducibility. Biometrics 45 (1989) 255-268